{'fraction_non_alphanumeric': 0.00966183574879227, 'fraction_numerical': 0.0, 'mean_word_length': 6.493975903614458, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pre‐delivery fibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption

Placental abruption is a severe obstetric complication of pregnancy that can cause disseminated intravascular coagulation and progress to massive post‐partum hemorrhage. Coagulation disorder due to extreme consumption of fibrinogen is considered the main pathogenesis of disseminated intravascular coagulation in patients with placental abruption. The present study sought to determine if the pre‐delivery fibrinogen level could predict adverse maternal or neonatal outcomes in patients with placental abruption.